Australia markets closed

Tempest Therapeutics Inc (3OS.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
3.2500+0.0480 (+1.50%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
17,498
17,498
22,527
17,166
14,389
Selling general and administrative
11,659
11,659
12,113
9,820
4,909
Total operating expenses
29,157
29,157
34,640
26,986
19,298
Operating income or loss
-29,157
-29,157
-34,640
-26,986
-19,298
Interest expense
1,449
1,449
1,618
1,282
0
Total other income/expenses net
15
15
-51
-41
-
Income before tax
-29,491
-29,491
-35,709
-28,302
-19,208
Income tax expense
0
0
0
0
0
Income from continuing operations
-29,491
-29,491
-35,709
-28,302
-19,208
Net income
-29,491
-29,491
-35,709
-28,302
-19,208
Net income available to common shareholders
-29,491
-29,491
-35,709
-28,302
-19,208
Basic EPS
-2.20
-1.91
-3.09
-7.47
-2.89
Diluted EPS
-2.20
-1.91
-3.09
-7.47
-2.89
Basic average shares
13,981
15,416
11,549
3,790
6,635
Diluted average shares
13,981
15,416
11,549
3,790
6,635